Downstream - Bioprocess Development Forum

Articles Downstream Upstream

December 5, 2019

New Therapies Present Scaling Challenges

Manufacturing differences between traditional mAb therapies and newer biotherapeutics dictate whether...

admin-element

Articles Downstream Upstream

October 24, 2019

Next Generation Bioprocesses: Mapping Roads to the Future

Increased productivity demand and a diversifying clinical drug pipeline have pushed the industry...

admin-element

Articles Downstream Regulatory

October 24, 2019

Best Practices for Selecting a Top-Quality Cell Line

Leveraging automation and a step-by-step approach are keys to success. Cell lines determine the...

admin-element

Articles Downstream Upstream

August 15, 2019

Monitoring and Control of Inline Dilution Processes

Buffer management has received less attention in process intensification despite the high costs and...

admin-element

Articles Downstream Regulatory Upstream

July 18, 2019

Design Considerations for a Commercial Cell and Gene Therapy Facility

The commercialization of cell and gene therapies has become a reality, prompting deeper...

admin-element

Articles BioPharma Downstream Regulatory Upstream

July 2, 2019

Addressing the Complex Nature of Downstream Processing with QbD

Regulators have been encouraging bio/pharmaceutical companies to incorporate the concept of...

admin-element

Articles BioPharma Downstream Regulatory Upstream

June 20, 2019

Moving PAT from Concept to Reality

Process analytical technology (PAT) is applied in the biopharmaceutical industry for analysis of raw...

admin-element

Articles BioPharma Downstream Upstream

May 9, 2019

Single-Use for Downstream Chromatography: Benefit or Hindrance?

Biopharmaceutical manufacturers have embraced the use of single-use technology upstream, but are...

admin-element

Articles Downstream

April 11, 2019

New HiScale™ 10/40 for Scale-Down Studies

Cytiva is pleased to announced the new HiScale™ 10/40. HiScale 10/40 column is especially suitable...

admin-element

Articles BioPharma Downstream Upstream

February 28, 2019

Bispecific Antibody Purification: Insights and Case Studies

New modalities, like bispecific antibodies, present unique challenges compared to mAb production.

admin-element